Champions Oncology Profit Margin

Champions Oncology posts a profit margin of -2.57% as of July 2026. That compares with 98.15% in the prior-year period — down 102.6% year over year. That is below the Healthcare sector average of 19.13%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Champions Oncology's profit margin was 98.15%. The latest reading is -2.57% — a 102.6% year-over-year decrease (period ending July 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 19.13% is typical. Champions Oncology's -2.57% is lower that level. That is roughly 113.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Champions Oncology's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -2.57% as of July 2026; use YoY and peer views to separate noise from signal.

Context for CSBR's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 19.13%), and (3) consistency with growth and profitability. This page covers the first two; Champions Oncology's other metric pages and overview cover the third.